Advanced Biomed is trading at $7.98, up +5.00%, as broader risk-on sentiment follows flat July PPI, cooler inflation, and slightly weaker jobless-claims data.
- No clear company-specific announcement was identified for August 13, 2026.
- The data reinforced expectations for steady Federal Reserve policy, while major indexes also rose, supporting growth-oriented shares.
- The move is best classified as macro-driven rather than company-specific.